TrialAnnals of the rheumatic diseases2004

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations.

S Generini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.